Skip to main content
. Author manuscript; available in PMC: 2019 Nov 11.
Published in final edited form as: Adv Drug Deliv Rev. 2018 Jul 21;130:113–130. doi: 10.1016/j.addr.2018.07.009

Figure 6.

Figure 6.

Schematic of ITCA 650 (A) and mean concentration-time profile of exenatide following implantation of ITCA 650 (B). With permission of Henry et al. Clinical therapeutics 35.5 (2013): 634-645. [100]